Idexx: Q4 EPS, Revenue Beat Forecast

Veterinary diagnostics specialist Idexx Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings on Monday, Feb. 3, that topped analysts' consensus top- and bottom-line estimates. Revenue for the quarter came in at $954 million against the expected $935 million. Earnings per share (EPS) came in at $2.62, exceeding the forecasted $2.40. The positive results were largely driven by strong growth in its Companion Animal Group (CAG) segment. Overall, Idexx enjoyed a solid quarter, reflecting its continuous progress and success in its markets.Source: Idexx Laboratories. Note: Analyst consensus estimates for the quarter provided by FactSet. YOY = Year over year. pps = Percentage points.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool